Our study also highlights the need to define how BRD2 regulate chromatin and transcription in processes such as cell-fate transitions and reprogramming in GBM, since BRD2 has been shown to play a role in chromatin organization (47,48) and its mutations have been associated with other CNS disorders (49). The gene discussed is BRD2; the disease is glioblastoma.